Oxytetracycline Injection Suppliers & Bulk Manufacturers
Available Forms: Injectable solution (IM, IV)
Available Strengths: 100 mg/mL or 250 mg/mL
Reference Brands: Terramycin (US & EU)
Category:
Veterinary Product
Oxytetracycline injection inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, leading to bacterial death. It effectively treats a wide range of bacterial infections in animals, reduces disease spread, and speeds recovery. Benefits include broad-spectrum activity, rapid action, and supporting animal health and productivity.
Oxytetracycline injection is available in Injectable solution (IM, IV)
and strengths such as 100 mg/mL or 250 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Oxytetracycline injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Oxytetracycline injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Oxytetracycline injection is approved in both the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, FDA approval requires comprehensive clinical data and safety evaluations, while in the EU, CE marking certifies conformity with veterinary medicinal regulations. These products undergo validation, stability testing, and extensive audits, with detailed documentation including safety profiles, clinical trial outcomes, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective oxytetracycline formulations vital for treating bacterial infections across various animal species worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing